These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 25787672

  • 1. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
    Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y.
    Circ J; 2015; 79(6):1349-56. PubMed ID: 25787672
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 3. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Dec; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 4. The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease.
    Kim HJ, Choi EH, Lim YJ, Kil HR.
    J Korean Med Sci; 2017 Jul; 32(7):1147-1153. PubMed ID: 28581272
    [Abstract] [Full Text] [Related]

  • 5. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 7. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
    Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
    [Abstract] [Full Text] [Related]

  • 8. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 26; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 9. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
    Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S.
    J Pediatr; 2016 Nov 26; 178():281-284.e1. PubMed ID: 27526622
    [Abstract] [Full Text] [Related]

  • 10. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 26; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 11. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct 26; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 12. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease.
    Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K.
    Circ J; 2014 Oct 26; 78(1):188-93. PubMed ID: 24152721
    [Abstract] [Full Text] [Related]

  • 13. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
    Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D.
    Arch Dis Child; 2011 Nov 26; 96(11):1088-90. PubMed ID: 20551193
    [Abstract] [Full Text] [Related]

  • 14. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
    Cho HJ, Bak SY, Kim SY, Yoo R, Baek HS, Yang S, Hwang IT, Ban JE.
    Pediatr Int; 2017 Jun 26; 59(6):669-674. PubMed ID: 28097746
    [Abstract] [Full Text] [Related]

  • 15. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome.
    Ueno K, Nomura Y, Hashiguchi T, Masuda K, Morita Y, Hazeki D, Eguchi T, Maruyama I, Kawano Y.
    Br J Haematol; 2010 Jan 26; 148(2):285-92. PubMed ID: 19793253
    [Abstract] [Full Text] [Related]

  • 16. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr 26; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 17. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
    Ha KS, Lee J, Jang GY, Lee J, Lee KC, Son CS, Lee JW.
    Am J Cardiol; 2015 Jul 15; 116(2):301-6. PubMed ID: 25975725
    [Abstract] [Full Text] [Related]

  • 18. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I.
    Clin Immunol; 2002 May 15; 103(2):161-8. PubMed ID: 12027421
    [Abstract] [Full Text] [Related]

  • 19. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Indian J Pediatr; 2019 Mar 15; 86(3):250-255. PubMed ID: 30159809
    [Abstract] [Full Text] [Related]

  • 20. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease　- A Multicenter Retrospective Study.
    Okuma Y, Suda K, Nakaoka H, Katsube Y, Mitani Y, Yoshikane Y, Ichida F, Matsushita T, Shichino H, Shiraishi I, Abe J, Hiroe M, Yoshida T, Imanaka-Yoshida K.
    Circ J; 2016 Oct 25; 80(11):2376-2381. PubMed ID: 27746411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.